A new internal memo from U.S. health regulators is prompting scrutiny of the FDA’s recent decision to authorize the first fruit-flavored e-cigarettes for adult smokers, according to multiple reports. The memo raises concerns that the authorized fruit-flavored products are not significantly more effective than tobacco-flavored e-cigarettes in helping adult users who smoke. The reporting frames the issue as part of the FDA’s evaluation of whether certain e-cigarettes provide a meaningful benefit compared with existing nicotine products, rather than simply changing flavor. While the FDA has moved to permit fruit-flavored options for adults, the memo suggests the evidence reviewed does not clearly demonstrate a distinct advantage over tobacco-flavored versions. The outlets also note that the authorizations and underlying assessments are likely to remain a subject of public and regulatory debate, given how flavor can affect product appeal and use patterns among smokers. The reports do not indicate that the authorized products are being immediately withdrawn, but they highlight the memo’s role in raising questions about the basis for the approval.